NEW YORK (GenomeWeb News) – A team from the US and Israel has characterized the genetic variation present in Burkholderia dolosa pathogens from cystic fibrosis patients with chronic B. dolosa infections that can be traced back to an outbreak that began in Boston in the 1990s — an analysis that offered a peek at the effects of adaptive mutations and selective pressures on such pathogen populations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.